The 7-Plex ProcartaPlex mouse antibody isotyping panel identifies the heavy chain subclasses of antibodies by analyzing 7 protein targets using Luminex xMAP technology. Isotyping of antibodies is a tool for...
The 7-Plex ProcartaPlex mouse antibody isotyping panel identifies the heavy chain subclasses of antibodies by analyzing 7 protein targets using Luminex xMAP technology. Antibodies isotyping is an essential and beneficial tool for hybridoma development. Simultaneous detection of these targets helps researchers analyze immunoglobulin isotypes during and after hybridoma development and evaluate immune responses. The panel is supplied in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X, requiring less pipeting and experimental configuration. It cannot be associated with simplexes or other panels.
ProcartaPlex preconfigured panels are widely tested for combinability, interference and cross-reactivity of analyses to provide the highest level of validation and accuracy. All ProcartaPlex panels are supplied with the reagents necessary to perform the dosage.
ProcartaPlex multiplex panels are available in several formats and can be used on six species (human, mouse, rat, non-human primate, porcine and canine).
Target list [microbille region]: IgA [38], IgE [42], IgG1 [12], IgG2a [18], IgG2b [21], IgG3 [25], IgM [52]
Recommended sample dilution: Serum, plasma: 1:10000; cell culture supernatant: 1:200
About ProcartaPlex strengths for Luminex platform
ProcartaPlex immunoassays are based on the principles of an ELISA Sandwich, using two highly specific antibodies binding to different epitopes of a protein to quantify all target proteins simultaneously using a Luminex instrument. ProcartaPlex multiplex assays require only 25 μl plasma or serum, or 50 μl cell culture supernatant, and only four hours to obtain the analyzed results.
• Reproducible and reliable results — validated in panel to the highest industry standard, with tests for protein target combinationability and cross-reactivity
• Plus of results per sampler — allows multiple protein targets to be achieved simultaneously in a single sample of 25 - 50 μl
• High-reference multiplexing platform with well established Luminex technology for protein detection and quantification
ProcartaPlex assays use Luminex xMAP (multianalyte profiling) Technology for simultaneous detection and quantification of up to 80 protein targets in a single 25–50 μl sample — plasma, serum, cell culture supernatant and other body fluids.
Luminex microbeads in the ProcartaPlex assay are coloured internally with precise proportions of red fluorophores and IR to create unique spectral signatures that can be identified by Luminex xMAP detection systems (e.g. Luminex 200, FLEXMAP 3D and MAGPIX). Like ELISA sandwich, the ProcartaPlex assay uses paired antibody pairs to identify the protein of interest. In a multiplexed assay, each single spectral microbead is marked with antibodies specific to a single target protein and the bound proteins are identified with biotinyl antibodies and streptavidine–R-phycoerythrin (RPE). Conjugation of specific antibodies from a protein to a separate microbead makes it possible to analyze several targets in a single well.
The most significant difference between a ProcartaPlex assay and a ELISA assay is that the ProcartaPlex capture antibody is conjugated with a microbead and is not adsorbed by any of the microplate wells. Thus, ProcartaPlex dosing reagents float freely in the solution. For detection purposes, Luminex 200, for example, contains two lasers: one to distinguish the spectral signature from each microbead and one to quantify the amount of fluorescence of RPE. The latter is proportional to the amount of protein present in the sample. Multiplex ProcartaPlex assays can profile more target proteins using a significantly smaller sample. It takes them as long as they do a traditional ELISA sandwich.